FIELD: medicine.
SUBSTANCE: pharmaceutical composition containing fibrin glue and a recovered homogenous cell population produced from human umbilical cord tissues in an amount effective to treat a disease; the umbilical cord tissue is substantially blood-free, is applied locally. The above recovered homogenous cell population is self-renewing and propagating in a culture, has a differentiation potential and does not express CD117 and/or telomerase.
EFFECT: using the given inventions enables increasing reperfusion in a patient suffering a peripheral vascular disease by the local use of umbilical cord tissue cells.
34 cl, 7 ex, 13 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS | 2013 |
|
RU2668389C2 |
| DETECTION OF CELLS OBTAINED FROM UMBILICAL CORD TISSUE | 2012 |
|
RU2636220C2 |
| TREATMENT OF DEGENERATIVE CHANGES IN INTERVERTEBRAL DISCS USING CELLS OBTAINED FROM HUMAN UMBILICAL TISSUE | 2012 |
|
RU2645079C2 |
| AMYOTROPHIC LATERAL SCLEROSIS TREATMENT USING CELLS OBTAINED FROM UMBILICAL CORD | 2012 |
|
RU2612391C2 |
| ENRICHED NUTRIENT MEDIUM FOR GROWING CELLS DERIVED FROM HUMAN UMBILICAL CORD TISSUE | 2013 |
|
RU2684306C2 |
| ENRICHED NUTRIENT MEDIUM FOR GROWING CELLS DERIVED FROM HUMAN UMBILICAL CORD TISSUE | 2013 |
|
RU2653449C2 |
| COMPOSITION AND METHODS OF CRYOPRESERVATION OF HUTC CELLS | 2017 |
|
RU2748057C2 |
| REPROGRAMMING HUMAN ENDOTHELIUM IN HEMATOPOIETIC PRECURSORS OF MULTIPLE LINES OF DIFFERENTIATION USING CERTAIN FACTORS | 2014 |
|
RU2691062C2 |
| TREATMENT WITH APPLICATION OF PRE-PROGRAMMED MATURE AND DIFFERENTIATED CELLS | 2009 |
|
RU2635317C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
